Soligenix Inc, Share Price Today: Live Updates & Key Insights

Soligenix Inc, share price today is $1.2, up -1.64%. The stock opened at $1.22 against the previous close of $1.22, with an intraday high of $1.23 and low of $1.15.

Soligenix Inc, Share Price Chart

Soligenix Inc,

us-stock
To Invest in {{usstockname}}
us-stock

Soligenix Inc, Share Price Performance

$1.2 -0.0164(-1.64%) SNGX at 23 Mar 2026 03:16 PM Biotechnology
Lowest Today 1.15
Highest Today 1.23
Today’s Open 1.22
Prev. Close 1.22
52 Week High 6.23
52 Week Low 1.02
Day’s Range: Low 1.15 High 1.23
52-Week Range: Low 1.02 High 6.23
1 day return -
1 Week return -3.25
1 month return +6.25
3 month return -11.19
6 month return -49.78
1 year return -48.7
3 year return -96.04
5 year return -99.71
10 year return -

Soligenix Inc, Institutional Holdings

DRW Securities, LLC 1.70

Vanguard Group Inc 0.85

Geode Capital Management, LLC 0.80

Fidelity Extended Market Index 0.57

Vanguard Institutional Extnd Mkt Idx Tr 0.54

Virtu Financial LLC 0.50

Jane Street Group LLC 0.38

Fidelity Series Total Market Index 0.09

Fidelity Total Market Index 0.08

Spartan Total Market Index Pool G 0.07

Morgan Stanley - Brokerage Accounts 0.04

Northern Trust Extended Eq Market Idx 0.02

NT Ext Equity Mkt Idx Fd - L 0.02

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.01

NT US Market Cap Idx Fd - L 0.00

Plante Moran Financial Advisors LP 0.00

State St US Extended Mkt Indx NL Cl C 0.00

UBS Group AG 0.00

NT Ext Equity Mkt Idx Fd - NL 0.00

BNYM Mellon SL Market Completion UC1 0.00

SSgA U.S. Total Market Index Strategy 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

IFP Advisors, LLC 0.00

Bank of America Corp 0.00

JONES FINANCIAL COMPANIES LLLP 0.00

State St US Ttl Mkt Indx NL Cl A 0.00

BNYM Mellon NSL Mkt Completion Fund Inst 0.00

CWM, LLC duplicate 0.00

Northern Trust Wilshire 5000 0.00

Advisor Group Holdings, Inc. 0.00

Albion Financial Group (Utah) 0.00

BlackRock Inc 0.00

Citadel Advisors Llc 0.00

Connective Capital Management LLC 0.00

NT Quality SCC US Fund - L 0.00

NT Quality Small Cap Core 0.00

SBI Securities Co Ltd 0.00

Tower Research Capital LLC 0.00

Two Sigma Investments LLC 0.00

Soligenix Inc, Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Soligenix Inc, Fundamentals

Market Cap 12.10 M

PB Ratio 1.5797

PE Ratio 0.0

Enterprise Value 1.86 M

Total Assets 8.97 M

Volume 150466

Soligenix Inc, Company Financials

Annual Revenue FY23:960615 1.0M, FY22:948911 0.9M, FY21:824268 0.8M, FY20:2359447 2.4M, FY19:4629916 4.6M

Annual Profit FY23:304248 0.3M, FY22:398089 0.4M, FY21:95628 0.1M, FY20:538498 0.5M, FY19:1062501 1.1M

Annual Net worth FY23:-8074390 -8.1M, FY22:-13798339 -13.8M, FY21:-12550973 -12.6M, FY20:-17688522 -17.7M, FY19:-9355592 -9.4M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:2342 0.0M

Quarterly Profit Q3/2025:0 0.0M, Q2/2025:-703 -0.0M, Q1/2025:-608 -0.0M, Q3/2024:0 0.0M, Q2/2024:-1588 -0.0M

Quarterly Net worth Q3/2025:-2530947 -2.5M, Q2/2025:-2701976 -2.7M, Q1/2025:-3236763 -3.2M, Q3/2024:-1719381 -1.7M, Q2/2024:-1644502 -1.6M

About Soligenix Inc, & investment objective

Company Information Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator (IDR) technology that is in Phase 3 clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX945, an IDR technology that is in Phase 2a study to treat aphthous ulcers in Behçet's disease; and SGX302, an IDR technology, which is in Phase 2a study for the treatment of mild-to-moderate psoriasis. Its Public Health Solutions segment engages in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase 1a, 1b, and 1c clinical trials; SGX943, a therapeutic candidate in preclinical studies for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; CiVax, a vaccine candidate for the prevention of COVID-19; and vaccine programs that target filoviruses, such as Marburg and Ebola. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in September 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.

Organisation Biotechnology

Employees 14

Industry Biotechnology

CEO Dr. Christopher J. Schaber Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Soligenix Inc, FAQs

What is the share price of Soligenix Inc, today?

The current share price of Soligenix Inc, is $1.2.

Can I buy Soligenix Inc, shares in India?

Yes, Indian investors can buy Soligenix Inc, shares by opening an international trading and demat account with Motilal Oswal.

How to buy Soligenix Inc, shares in India?

You can easily invest in Soligenix Inc, shares from India by:

Can I buy fractional shares of Soligenix Inc,?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Soligenix Inc,?

Soligenix Inc, has a market cap of $12.10 M.

In which sector does Soligenix Inc, belong?

Soligenix Inc, operates in the Biotechnology sector.

What documents are required to invest in Soligenix Inc, stocks?

To invest, you typically need:

What is the PE and PB ratio of Soligenix Inc,?

The PE ratio of Soligenix Inc, is N/A and the PB ratio is 1.58.